GR1007628B - Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου - Google Patents

Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου

Info

Publication number
GR1007628B
GR1007628B GR20110100444A GR20110100444A GR1007628B GR 1007628 B GR1007628 B GR 1007628B GR 20110100444 A GR20110100444 A GR 20110100444A GR 20110100444 A GR20110100444 A GR 20110100444A GR 1007628 B GR1007628 B GR 1007628B
Authority
GR
Greece
Prior art keywords
preparation
pharmaceutical composition
antimuscarinic agent
composition containing
coating layer
Prior art date
Application number
GR20110100444A
Other languages
English (en)
Inventor
Ευαγγελος Ανδρεα Καραβας
Ευθυμιος Χρηστου Κουτρης
Ιωαννα Χρηστου Κουτρη
Βικυ Χρηστου Σαμαρα
Δημητριος Νικολαου Μπικιαρης
Αθηνα Γεωργιου Ηλιοπουλου
Original Assignee
Φαρματεν Αβεε,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Φαρματεν Αβεε, filed Critical Φαρματεν Αβεε,
Priority to GR20110100444A priority Critical patent/GR1007628B/el
Publication of GR1007628B publication Critical patent/GR1007628B/el
Priority to EP12751445.3A priority patent/EP2736496B1/en
Priority to DK12751445.3T priority patent/DK2736496T3/en
Priority to PCT/EP2012/003076 priority patent/WO2013013798A1/en
Priority to ES12751445T priority patent/ES2697609T3/es
Priority to PL12751445T priority patent/PL2736496T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά αφενός φαρμακοτεχνική σύνθεση τροποποιημένης αποδέσμευσης για χορήγηση διά στόματος, η οποία περιέχει ως δραστική ουσία ποσότητα ενός αντιμουσκαρινικού παράγοντα όπως η Τολτεροδίνη ή κάποιο φαρμακευτικά αποδεκτό άλας, παράγωγο, προφάρμακο ή μεταβολίτη αυτής, που εσωκλείεται στον πυρήνα μιας μήτρας, ο οποίος πυρήνας επικαλύπτεται με μια πρώτη στρώση ενός υδρόφοβου πολυμερούς και μια δεύτερη στρώση ενός πολυμερούς ανθεκτικού στο γαστρικό ρΗ και αφετέρου τη μέθοδο παρασκευής αυτής της σύνθεσης.
GR20110100444A 2011-07-27 2011-07-27 Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου GR1007628B (el)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GR20110100444A GR1007628B (el) 2011-07-27 2011-07-27 Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου
EP12751445.3A EP2736496B1 (en) 2011-07-27 2012-07-20 Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof
DK12751445.3T DK2736496T3 (en) 2011-07-27 2012-07-20 PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-MUSCARINE AND PROCEDURE FOR PREPARING THEREOF
PCT/EP2012/003076 WO2013013798A1 (en) 2011-07-27 2012-07-20 Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof
ES12751445T ES2697609T3 (es) 2011-07-27 2012-07-20 Composición farmacéutica que contiene un agente antimuscarínico y método para la preparación del mismo
PL12751445T PL2736496T3 (pl) 2011-07-27 2012-07-20 Kompozycja farmaceutyczna zawierająca środek przeciwmuskarynowy i sposób jej wytwarzania

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20110100444A GR1007628B (el) 2011-07-27 2011-07-27 Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου

Publications (1)

Publication Number Publication Date
GR1007628B true GR1007628B (el) 2012-06-29

Family

ID=45814524

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20110100444A GR1007628B (el) 2011-07-27 2011-07-27 Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου

Country Status (6)

Country Link
EP (1) EP2736496B1 (el)
DK (1) DK2736496T3 (el)
ES (1) ES2697609T3 (el)
GR (1) GR1007628B (el)
PL (1) PL2736496T3 (el)
WO (1) WO2013013798A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015022703A1 (en) * 2013-08-12 2015-02-19 Genepharm India Private Limited A stable pharmaceutical composition of fesoterodine hydrochloride

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1731142A1 (en) * 2005-06-08 2006-12-13 Dexcel Pharma Technologies Ltd. Specific time-delayed burst profile delivery system
EP1810668A1 (en) * 2006-01-23 2007-07-25 LEK Pharmaceuticals D.D. Coated formulations containing tolterodine tartrate
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
WO2010096820A1 (en) * 2009-02-23 2010-08-26 Eurand, Inc. Controlled release compositions comprising anti-cholinergic drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
WO2005105036A1 (en) * 2004-04-28 2005-11-10 Natco Pharma Limited Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation
WO2007029087A2 (en) 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Controlled release multiple unit formulations
WO2007122015A1 (en) 2006-04-21 2007-11-01 Synthon B.V. Tolterodine beads

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1731142A1 (en) * 2005-06-08 2006-12-13 Dexcel Pharma Technologies Ltd. Specific time-delayed burst profile delivery system
EP1810668A1 (en) * 2006-01-23 2007-07-25 LEK Pharmaceuticals D.D. Coated formulations containing tolterodine tartrate
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
WO2010096820A1 (en) * 2009-02-23 2010-08-26 Eurand, Inc. Controlled release compositions comprising anti-cholinergic drugs

Also Published As

Publication number Publication date
EP2736496B1 (en) 2018-09-05
ES2697609T3 (es) 2019-01-25
PL2736496T3 (pl) 2019-02-28
EP2736496A1 (en) 2014-06-04
WO2013013798A1 (en) 2013-01-31
DK2736496T3 (en) 2019-01-07

Similar Documents

Publication Publication Date Title
EA201391483A1 (ru) Фармацевтическая композиция
BRPI0823128A2 (pt) Composição farmacêutica de liberação controlada dependente do ph para não opioides com resistência contra a influência de etanol.
WO2012021629A3 (en) Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
CL2012002909A1 (es) Procedimiento de preparación de una composición farmacéutica que comprenden a) un centro granulado constituido por granos de principio activo aglomerados en presencia de aglomerante y b) una capa de recubrimiento de dicho centro granulado constituido por matriz grasa; composición farmacéutica; y su uso para administración oral
BR112014003802A2 (pt) composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento
BRPI0823096A2 (pt) Composição de opioide farmacêutica de liberação controlada, dependente do ph, com resistência contra a influência do etanol
CL2014002283A1 (es) Forma de dosificacion oral solida de liberacion inmediata que comprende particulas que comprenden un nucleo con un primer agente activo, un recubrimiento con un segundo agente activo sobre el y un material sensible al ph acido sobre dicho nucleo recubierto; proceso para prepararla; metodo de tratamiento; y uso para tratar dolor.
BRPI0818680A2 (pt) composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
BRPI1007725A2 (pt) composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma
WO2011106416A3 (en) Abuse-resistant formulations
EP2771043A4 (en) ACTIVE RELEASE PROCEDURE
WO2011099832A3 (en) Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
EP2329810A4 (en) DRUG DISPENSING SYSTEM WITH MAGNETIC RETENTION, MANUFACTURING PROCESS AND APPLICATION
MX360389B (es) Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico.
WO2013009142A3 (en) Sustained/release pharmaceutical composition comripising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same
EP2666773A8 (en) Organic amine salts of azilsartan, preparation method and use thereof
WO2013083826A3 (en) Glp-1 agonists
PL3067353T3 (pl) Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowania
NZ627468A (en) Hydrocortisone controlled release formulation
WO2013017910A8 (en) Extended release pharmaceutical compositions containing paliperidone
PL393261A1 (pl) Sposób wytwarzania kapsułek z hydrofilowym rdzeniem i polimerową otoczką
WO2014181195A3 (en) Antiemetic extended release solid dosage forms
HUE041795T2 (hu) Bevonószer szilárd gyógyszerészeti készítményhez, gyógyszerészeti filmkészítmény, és bevonatos szilárd gyógyszerészeti készítmény
BR112013007904A2 (pt) "composto, composição farmacêutica, medicamento, uso de um composto e proceso para preparar um composto"
WO2012014052A3 (en) Novel coated extended release pharmaceutical compositions containing paliperidone

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20120713

ML Lapse due to non-payment of fees

Effective date: 20170207